Loading…

New Strategies for the Treatment of Neuropsychiatric Disorders Based on Reelin Dysfunction

Reelin is an extracellular matrix protein that is mainly produced in Cajal-Retzius cells and controls neuronal migration, which is important for the proper formation of cortical layers in the developmental stage of the brain. In the adult brain, Reelin plays a crucial role in the regulation of -meth...

Full description

Saved in:
Bibliographic Details
Published in:International journal of molecular sciences 2022-02, Vol.23 (3), p.1829
Main Authors: Tsuneura, Yumi, Nakai, Tsuyoshi, Mizoguchi, Hiroyuki, Yamada, Kiyofumi
Format: Article
Language:English
Subjects:
Citations: Items that this one cites
Items that cite this one
Online Access:Get full text
Tags: Add Tag
No Tags, Be the first to tag this record!
cited_by cdi_FETCH-LOGICAL-c478t-5182506cdaba4a02aba8cf45a27f1813adb2cf753f831223d6277504b718ca0f3
cites cdi_FETCH-LOGICAL-c478t-5182506cdaba4a02aba8cf45a27f1813adb2cf753f831223d6277504b718ca0f3
container_end_page
container_issue 3
container_start_page 1829
container_title International journal of molecular sciences
container_volume 23
creator Tsuneura, Yumi
Nakai, Tsuyoshi
Mizoguchi, Hiroyuki
Yamada, Kiyofumi
description Reelin is an extracellular matrix protein that is mainly produced in Cajal-Retzius cells and controls neuronal migration, which is important for the proper formation of cortical layers in the developmental stage of the brain. In the adult brain, Reelin plays a crucial role in the regulation of -methyl-D-aspartate receptor-dependent synaptic function, and its expression decreases postnatally. Clinical studies showed reductions in Reelin protein and mRNA expression levels in patients with psychiatric disorders; however, the causal relationship remains unclear. Reelin-deficient mice exhibit an abnormal neuronal morphology and behavior, while Reelin supplementation ameliorates learning deficits, synaptic dysfunctions, and spine loss in animal models with Reelin deficiency. These findings suggest that the neuronal deficits and brain dysfunctions associated with the down-regulated expression of Reelin are attenuated by enhancements in its expression and functions in the brain. In this review, we summarize findings on the role of Reelin in neuropsychiatric disorders and discuss potential therapeutic approaches for neuropsychiatric disorders associated with Reelin dysfunctions.
doi_str_mv 10.3390/ijms23031829
format article
fullrecord <record><control><sourceid>proquest_pubme</sourceid><recordid>TN_cdi_pubmedcentral_primary_oai_pubmedcentral_nih_gov_8836358</recordid><sourceformat>XML</sourceformat><sourcesystem>PC</sourcesystem><sourcerecordid>2627669268</sourcerecordid><originalsourceid>FETCH-LOGICAL-c478t-5182506cdaba4a02aba8cf45a27f1813adb2cf753f831223d6277504b718ca0f3</originalsourceid><addsrcrecordid>eNpdkUtrGzEUhUVpaF7dZR0E3WQRp3qMHrMp5NEmgeBCmm66EbLmKpaZGTmSpsX_PmOcBDerc-F-HM7hIHREyRnnNfkaFl1mnHCqWf0B7dGKsQkhUn3cunfRfs4LQhhnov6EdrmgkitB99CfKfzDv0qyBR4DZOxjwmUO-CGBLR30BUePpzCkuMwrNw-2pODwVcgxNZAyvrAZGhx7fA_Qhh5frbIfeldC7A_Rjrdths8veoB-__j-cHkzuft5fXt5fjdxldJlIsbggkjX2JmtLGGjaOcrYZnyVFNumxlzXgnuNaeM8UYypQSpZopqZ4nnB-jbxnc5zDpo3Bg62dYsU-hsWplog_n_04e5eYx_jdZccqFHg5MXgxSfBsjFdCE7aFvbQxyyYZLVRCgqqxH98g5dxCH1Y701paSsmVwbnm4ol2LOCfxbGErMejSzPdqIH28XeINfV-LPFbyTxw</addsrcrecordid><sourcetype>Open Access Repository</sourcetype><iscdi>true</iscdi><recordtype>article</recordtype><pqid>2627669268</pqid></control><display><type>article</type><title>New Strategies for the Treatment of Neuropsychiatric Disorders Based on Reelin Dysfunction</title><source>Publicly Available Content Database</source><source>PubMed Central</source><creator>Tsuneura, Yumi ; Nakai, Tsuyoshi ; Mizoguchi, Hiroyuki ; Yamada, Kiyofumi</creator><creatorcontrib>Tsuneura, Yumi ; Nakai, Tsuyoshi ; Mizoguchi, Hiroyuki ; Yamada, Kiyofumi</creatorcontrib><description>Reelin is an extracellular matrix protein that is mainly produced in Cajal-Retzius cells and controls neuronal migration, which is important for the proper formation of cortical layers in the developmental stage of the brain. In the adult brain, Reelin plays a crucial role in the regulation of -methyl-D-aspartate receptor-dependent synaptic function, and its expression decreases postnatally. Clinical studies showed reductions in Reelin protein and mRNA expression levels in patients with psychiatric disorders; however, the causal relationship remains unclear. Reelin-deficient mice exhibit an abnormal neuronal morphology and behavior, while Reelin supplementation ameliorates learning deficits, synaptic dysfunctions, and spine loss in animal models with Reelin deficiency. These findings suggest that the neuronal deficits and brain dysfunctions associated with the down-regulated expression of Reelin are attenuated by enhancements in its expression and functions in the brain. In this review, we summarize findings on the role of Reelin in neuropsychiatric disorders and discuss potential therapeutic approaches for neuropsychiatric disorders associated with Reelin dysfunctions.</description><identifier>ISSN: 1422-0067</identifier><identifier>ISSN: 1661-6596</identifier><identifier>EISSN: 1422-0067</identifier><identifier>DOI: 10.3390/ijms23031829</identifier><identifier>PMID: 35163751</identifier><language>eng</language><publisher>Switzerland: MDPI AG</publisher><subject>Alzheimer's disease ; Animal models ; Animals ; Brain ; Extracellular matrix ; Gene expression ; Gene Expression Regulation, Developmental ; Glutamic acid receptors ; Humans ; Kinases ; Learning ; Matrix protein ; Mental disorders ; Mental Disorders - drug therapy ; Mental Disorders - metabolism ; Mice ; Molecular Targeted Therapy ; Morphology ; N-Methyl-D-aspartic acid receptors ; Phosphorylation ; Proteins ; Psychotropic drugs ; Reelin protein ; Reelin Protein - genetics ; Reelin Protein - metabolism ; Review ; Schizophrenia</subject><ispartof>International journal of molecular sciences, 2022-02, Vol.23 (3), p.1829</ispartof><rights>2022 by the authors. Licensee MDPI, Basel, Switzerland. This article is an open access article distributed under the terms and conditions of the Creative Commons Attribution (CC BY) license (https://creativecommons.org/licenses/by/4.0/). Notwithstanding the ProQuest Terms and Conditions, you may use this content in accordance with the terms of the License.</rights><rights>2022 by the authors. 2022</rights><lds50>peer_reviewed</lds50><oa>free_for_read</oa><woscitedreferencessubscribed>false</woscitedreferencessubscribed><citedby>FETCH-LOGICAL-c478t-5182506cdaba4a02aba8cf45a27f1813adb2cf753f831223d6277504b718ca0f3</citedby><cites>FETCH-LOGICAL-c478t-5182506cdaba4a02aba8cf45a27f1813adb2cf753f831223d6277504b718ca0f3</cites><orcidid>0000-0002-2373-2752</orcidid></display><links><openurl>$$Topenurl_article</openurl><openurlfulltext>$$Topenurlfull_article</openurlfulltext><thumbnail>$$Tsyndetics_thumb_exl</thumbnail><linktopdf>$$Uhttps://www.proquest.com/docview/2627669268/fulltextPDF?pq-origsite=primo$$EPDF$$P50$$Gproquest$$Hfree_for_read</linktopdf><linktohtml>$$Uhttps://www.proquest.com/docview/2627669268?pq-origsite=primo$$EHTML$$P50$$Gproquest$$Hfree_for_read</linktohtml><link.rule.ids>230,314,727,780,784,885,25752,27923,27924,37011,37012,44589,53790,53792,74897</link.rule.ids><backlink>$$Uhttps://www.ncbi.nlm.nih.gov/pubmed/35163751$$D View this record in MEDLINE/PubMed$$Hfree_for_read</backlink></links><search><creatorcontrib>Tsuneura, Yumi</creatorcontrib><creatorcontrib>Nakai, Tsuyoshi</creatorcontrib><creatorcontrib>Mizoguchi, Hiroyuki</creatorcontrib><creatorcontrib>Yamada, Kiyofumi</creatorcontrib><title>New Strategies for the Treatment of Neuropsychiatric Disorders Based on Reelin Dysfunction</title><title>International journal of molecular sciences</title><addtitle>Int J Mol Sci</addtitle><description>Reelin is an extracellular matrix protein that is mainly produced in Cajal-Retzius cells and controls neuronal migration, which is important for the proper formation of cortical layers in the developmental stage of the brain. In the adult brain, Reelin plays a crucial role in the regulation of -methyl-D-aspartate receptor-dependent synaptic function, and its expression decreases postnatally. Clinical studies showed reductions in Reelin protein and mRNA expression levels in patients with psychiatric disorders; however, the causal relationship remains unclear. Reelin-deficient mice exhibit an abnormal neuronal morphology and behavior, while Reelin supplementation ameliorates learning deficits, synaptic dysfunctions, and spine loss in animal models with Reelin deficiency. These findings suggest that the neuronal deficits and brain dysfunctions associated with the down-regulated expression of Reelin are attenuated by enhancements in its expression and functions in the brain. In this review, we summarize findings on the role of Reelin in neuropsychiatric disorders and discuss potential therapeutic approaches for neuropsychiatric disorders associated with Reelin dysfunctions.</description><subject>Alzheimer's disease</subject><subject>Animal models</subject><subject>Animals</subject><subject>Brain</subject><subject>Extracellular matrix</subject><subject>Gene expression</subject><subject>Gene Expression Regulation, Developmental</subject><subject>Glutamic acid receptors</subject><subject>Humans</subject><subject>Kinases</subject><subject>Learning</subject><subject>Matrix protein</subject><subject>Mental disorders</subject><subject>Mental Disorders - drug therapy</subject><subject>Mental Disorders - metabolism</subject><subject>Mice</subject><subject>Molecular Targeted Therapy</subject><subject>Morphology</subject><subject>N-Methyl-D-aspartic acid receptors</subject><subject>Phosphorylation</subject><subject>Proteins</subject><subject>Psychotropic drugs</subject><subject>Reelin protein</subject><subject>Reelin Protein - genetics</subject><subject>Reelin Protein - metabolism</subject><subject>Review</subject><subject>Schizophrenia</subject><issn>1422-0067</issn><issn>1661-6596</issn><issn>1422-0067</issn><fulltext>true</fulltext><rsrctype>article</rsrctype><creationdate>2022</creationdate><recordtype>article</recordtype><sourceid>PIMPY</sourceid><recordid>eNpdkUtrGzEUhUVpaF7dZR0E3WQRp3qMHrMp5NEmgeBCmm66EbLmKpaZGTmSpsX_PmOcBDerc-F-HM7hIHREyRnnNfkaFl1mnHCqWf0B7dGKsQkhUn3cunfRfs4LQhhnov6EdrmgkitB99CfKfzDv0qyBR4DZOxjwmUO-CGBLR30BUePpzCkuMwrNw-2pODwVcgxNZAyvrAZGhx7fA_Qhh5frbIfeldC7A_Rjrdths8veoB-__j-cHkzuft5fXt5fjdxldJlIsbggkjX2JmtLGGjaOcrYZnyVFNumxlzXgnuNaeM8UYypQSpZopqZ4nnB-jbxnc5zDpo3Bg62dYsU-hsWplog_n_04e5eYx_jdZccqFHg5MXgxSfBsjFdCE7aFvbQxyyYZLVRCgqqxH98g5dxCH1Y701paSsmVwbnm4ol2LOCfxbGErMejSzPdqIH28XeINfV-LPFbyTxw</recordid><startdate>20220206</startdate><enddate>20220206</enddate><creator>Tsuneura, Yumi</creator><creator>Nakai, Tsuyoshi</creator><creator>Mizoguchi, Hiroyuki</creator><creator>Yamada, Kiyofumi</creator><general>MDPI AG</general><general>MDPI</general><scope>CGR</scope><scope>CUY</scope><scope>CVF</scope><scope>ECM</scope><scope>EIF</scope><scope>NPM</scope><scope>AAYXX</scope><scope>CITATION</scope><scope>3V.</scope><scope>7X7</scope><scope>7XB</scope><scope>88E</scope><scope>8FI</scope><scope>8FJ</scope><scope>8FK</scope><scope>8G5</scope><scope>ABUWG</scope><scope>AFKRA</scope><scope>AZQEC</scope><scope>BENPR</scope><scope>CCPQU</scope><scope>DWQXO</scope><scope>FYUFA</scope><scope>GHDGH</scope><scope>GNUQQ</scope><scope>GUQSH</scope><scope>K9.</scope><scope>M0S</scope><scope>M1P</scope><scope>M2O</scope><scope>MBDVC</scope><scope>PIMPY</scope><scope>PQEST</scope><scope>PQQKQ</scope><scope>PQUKI</scope><scope>PRINS</scope><scope>Q9U</scope><scope>7X8</scope><scope>5PM</scope><orcidid>https://orcid.org/0000-0002-2373-2752</orcidid></search><sort><creationdate>20220206</creationdate><title>New Strategies for the Treatment of Neuropsychiatric Disorders Based on Reelin Dysfunction</title><author>Tsuneura, Yumi ; Nakai, Tsuyoshi ; Mizoguchi, Hiroyuki ; Yamada, Kiyofumi</author></sort><facets><frbrtype>5</frbrtype><frbrgroupid>cdi_FETCH-LOGICAL-c478t-5182506cdaba4a02aba8cf45a27f1813adb2cf753f831223d6277504b718ca0f3</frbrgroupid><rsrctype>articles</rsrctype><prefilter>articles</prefilter><language>eng</language><creationdate>2022</creationdate><topic>Alzheimer's disease</topic><topic>Animal models</topic><topic>Animals</topic><topic>Brain</topic><topic>Extracellular matrix</topic><topic>Gene expression</topic><topic>Gene Expression Regulation, Developmental</topic><topic>Glutamic acid receptors</topic><topic>Humans</topic><topic>Kinases</topic><topic>Learning</topic><topic>Matrix protein</topic><topic>Mental disorders</topic><topic>Mental Disorders - drug therapy</topic><topic>Mental Disorders - metabolism</topic><topic>Mice</topic><topic>Molecular Targeted Therapy</topic><topic>Morphology</topic><topic>N-Methyl-D-aspartic acid receptors</topic><topic>Phosphorylation</topic><topic>Proteins</topic><topic>Psychotropic drugs</topic><topic>Reelin protein</topic><topic>Reelin Protein - genetics</topic><topic>Reelin Protein - metabolism</topic><topic>Review</topic><topic>Schizophrenia</topic><toplevel>peer_reviewed</toplevel><toplevel>online_resources</toplevel><creatorcontrib>Tsuneura, Yumi</creatorcontrib><creatorcontrib>Nakai, Tsuyoshi</creatorcontrib><creatorcontrib>Mizoguchi, Hiroyuki</creatorcontrib><creatorcontrib>Yamada, Kiyofumi</creatorcontrib><collection>Medline</collection><collection>MEDLINE</collection><collection>MEDLINE (Ovid)</collection><collection>MEDLINE</collection><collection>MEDLINE</collection><collection>PubMed</collection><collection>CrossRef</collection><collection>ProQuest Central (Corporate)</collection><collection>Health &amp; Medical Collection</collection><collection>ProQuest Central (purchase pre-March 2016)</collection><collection>Medical Database (Alumni Edition)</collection><collection>Hospital Premium Collection</collection><collection>Hospital Premium Collection (Alumni Edition)</collection><collection>ProQuest Central (Alumni) (purchase pre-March 2016)</collection><collection>Research Library (Alumni Edition)</collection><collection>ProQuest Central (Alumni)</collection><collection>ProQuest Central</collection><collection>ProQuest Central Essentials</collection><collection>ProQuest Central</collection><collection>ProQuest One Community College</collection><collection>ProQuest Central</collection><collection>Health Research Premium Collection</collection><collection>Health Research Premium Collection (Alumni)</collection><collection>ProQuest Central Student</collection><collection>Research Library Prep</collection><collection>ProQuest Health &amp; Medical Complete (Alumni)</collection><collection>Health &amp; Medical Collection (Alumni Edition)</collection><collection>Medical Database</collection><collection>Research Library</collection><collection>Research Library (Corporate)</collection><collection>Publicly Available Content Database</collection><collection>ProQuest One Academic Eastern Edition (DO NOT USE)</collection><collection>ProQuest One Academic</collection><collection>ProQuest One Academic UKI Edition</collection><collection>ProQuest Central China</collection><collection>ProQuest Central Basic</collection><collection>MEDLINE - Academic</collection><collection>PubMed Central (Full Participant titles)</collection><jtitle>International journal of molecular sciences</jtitle></facets><delivery><delcategory>Remote Search Resource</delcategory><fulltext>fulltext</fulltext></delivery><addata><au>Tsuneura, Yumi</au><au>Nakai, Tsuyoshi</au><au>Mizoguchi, Hiroyuki</au><au>Yamada, Kiyofumi</au><format>journal</format><genre>article</genre><ristype>JOUR</ristype><atitle>New Strategies for the Treatment of Neuropsychiatric Disorders Based on Reelin Dysfunction</atitle><jtitle>International journal of molecular sciences</jtitle><addtitle>Int J Mol Sci</addtitle><date>2022-02-06</date><risdate>2022</risdate><volume>23</volume><issue>3</issue><spage>1829</spage><pages>1829-</pages><issn>1422-0067</issn><issn>1661-6596</issn><eissn>1422-0067</eissn><abstract>Reelin is an extracellular matrix protein that is mainly produced in Cajal-Retzius cells and controls neuronal migration, which is important for the proper formation of cortical layers in the developmental stage of the brain. In the adult brain, Reelin plays a crucial role in the regulation of -methyl-D-aspartate receptor-dependent synaptic function, and its expression decreases postnatally. Clinical studies showed reductions in Reelin protein and mRNA expression levels in patients with psychiatric disorders; however, the causal relationship remains unclear. Reelin-deficient mice exhibit an abnormal neuronal morphology and behavior, while Reelin supplementation ameliorates learning deficits, synaptic dysfunctions, and spine loss in animal models with Reelin deficiency. These findings suggest that the neuronal deficits and brain dysfunctions associated with the down-regulated expression of Reelin are attenuated by enhancements in its expression and functions in the brain. In this review, we summarize findings on the role of Reelin in neuropsychiatric disorders and discuss potential therapeutic approaches for neuropsychiatric disorders associated with Reelin dysfunctions.</abstract><cop>Switzerland</cop><pub>MDPI AG</pub><pmid>35163751</pmid><doi>10.3390/ijms23031829</doi><orcidid>https://orcid.org/0000-0002-2373-2752</orcidid><oa>free_for_read</oa></addata></record>
fulltext fulltext
identifier ISSN: 1422-0067
ispartof International journal of molecular sciences, 2022-02, Vol.23 (3), p.1829
issn 1422-0067
1661-6596
1422-0067
language eng
recordid cdi_pubmedcentral_primary_oai_pubmedcentral_nih_gov_8836358
source Publicly Available Content Database; PubMed Central
subjects Alzheimer's disease
Animal models
Animals
Brain
Extracellular matrix
Gene expression
Gene Expression Regulation, Developmental
Glutamic acid receptors
Humans
Kinases
Learning
Matrix protein
Mental disorders
Mental Disorders - drug therapy
Mental Disorders - metabolism
Mice
Molecular Targeted Therapy
Morphology
N-Methyl-D-aspartic acid receptors
Phosphorylation
Proteins
Psychotropic drugs
Reelin protein
Reelin Protein - genetics
Reelin Protein - metabolism
Review
Schizophrenia
title New Strategies for the Treatment of Neuropsychiatric Disorders Based on Reelin Dysfunction
url http://sfxeu10.hosted.exlibrisgroup.com/loughborough?ctx_ver=Z39.88-2004&ctx_enc=info:ofi/enc:UTF-8&ctx_tim=2025-01-12T18%3A46%3A03IST&url_ver=Z39.88-2004&url_ctx_fmt=infofi/fmt:kev:mtx:ctx&rfr_id=info:sid/primo.exlibrisgroup.com:primo3-Article-proquest_pubme&rft_val_fmt=info:ofi/fmt:kev:mtx:journal&rft.genre=article&rft.atitle=New%20Strategies%20for%20the%20Treatment%20of%20Neuropsychiatric%20Disorders%20Based%20on%20Reelin%20Dysfunction&rft.jtitle=International%20journal%20of%20molecular%20sciences&rft.au=Tsuneura,%20Yumi&rft.date=2022-02-06&rft.volume=23&rft.issue=3&rft.spage=1829&rft.pages=1829-&rft.issn=1422-0067&rft.eissn=1422-0067&rft_id=info:doi/10.3390/ijms23031829&rft_dat=%3Cproquest_pubme%3E2627669268%3C/proquest_pubme%3E%3Cgrp_id%3Ecdi_FETCH-LOGICAL-c478t-5182506cdaba4a02aba8cf45a27f1813adb2cf753f831223d6277504b718ca0f3%3C/grp_id%3E%3Coa%3E%3C/oa%3E%3Curl%3E%3C/url%3E&rft_id=info:oai/&rft_pqid=2627669268&rft_id=info:pmid/35163751&rfr_iscdi=true